MedKoo Cat#: 461273 | Name: RG 12915

Description:

WARNING: This product is for research use only, not for human or veterinary use.

RG 12915 is a potent, selective 5-HT3 receptor antagonist developed for the treatment of emesis and nausea associated with cancer chemotherapy.

Chemical Structure

RG 12915
RG 12915
CAS#125363-06-6

Theoretical Analysis

MedKoo Cat#: 461273

Name: RG 12915

CAS#: 125363-06-6

Chemical Formula: C20H25ClN2O2

Exact Mass: 360.1605

Molecular Weight: 360.88

Elemental Analysis: C, 66.56; H, 6.98; Cl, 9.82; N, 7.76; O, 8.87

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
136174-04-4;
Synonym
RG 12915; RG-12915; RG12915; 136174-04-4;
IUPAC/Chemical Name
2-chloro-N-(quinuclidin-3-yl)-5a,6,7,8,9,9a-hexahydrodibenzo[b,d]furan-4-carboxamide
InChi Key
LDYMIBZOCSHLBG-UHFFFAOYSA-N
InChi Code
InChI=1S/C20H25ClN2O2/c21-13-9-15-14-3-1-2-4-18(14)25-19(15)16(10-13)20(24)22-17-11-23-7-5-12(17)6-8-23/h9-10,12,14,17-18H,1-8,11H2,(H,22,24)
SMILES Code
O=C(C1=C2OC(CCCC3)C3C2=CC(Cl)=C1)NC4CN5CCC4CC5
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 360.88 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Lerman SA, Delongeas JL, Plard JP, Veneziale RW, Clark RL, Rubin L, Sanders JE. Cataractogenesis in rats induced by in utero exposure to RG 12915, a 5-HT3 antagonist. Fundam Appl Toxicol. 1995 Sep;27(2):270-6. PubMed PMID: 8529823. 2: Baltzer L, Kris MG, Tyson LB, Rigas JR, Vreeland F, Pisters KM. Dose-ranging antiemetic evaluation of the serotonin antagonist RG 12915 in patients receiving anticancer chemotherapy. Cancer. 1993 Nov 1;72(9):2695-9. PubMed PMID: 8402492. 3: Fitzpatrick LR, Lambert RM, Pendley CE, Martin GE, Bostwick JS, Gessner GW, Airey JE, Youssefyeh RD, Pendleton RG, Decktor DL. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog. J Pharmacol Exp Ther. 1990 Aug;254(2):450-5. PubMed PMID: 2166791.